April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Periocular Distribution of Nepafenac and Amfenac after Topical Administation of Nepafenac in the Rabbit
Author Affiliations & Notes
  • S. M. Hariprasad
    Ophthalmology, University of Chicago, Chicago, Illinois
  • M. Sanders
    Alcon Research, Ltd., Fort Worth, Texas
  • J. Chastain
    Alcon Research, Ltd., Fort Worth, Texas
  • M. Curtis
    Alcon Research, Ltd., Fort Worth, Texas
  • R. Faulkner
    Alcon Research, Ltd., Fort Worth, Texas
  • D. Dahlin
    Alcon Research, Ltd., Fort Worth, Texas
  • Footnotes
    Commercial Relationships  S.M. Hariprasad, Alcon Research, Ltd., C; Alcon Research, Ltd., R; M. Sanders, Alcon Research, Ltd., E; J. Chastain, Alcon Research, Ltd., E; M. Curtis, Alcon Research, Ltd., E; R. Faulkner, Alcon Research, Ltd., E; D. Dahlin, al, E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5999. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. M. Hariprasad, M. Sanders, J. Chastain, M. Curtis, R. Faulkner, D. Dahlin; Periocular Distribution of Nepafenac and Amfenac after Topical Administation of Nepafenac in the Rabbit. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5999.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate the periocular distrubtion of the amide prodrug, nepafenac, and its active metabolite, amfenac, following topical ocular administration.

Methods: : Single topical ocular doses of 0.1% nepafenac ophthalmic suspension were instilled unilaterally in New Zealand White rabbits. Ocular tissue samples were collected from both dosed (OD) and undosed (OS) eyes at intervals out to 48 hours. Nepafenac and amfenac tissue concentrations were determined by a validated LC/MS/MS method.

Results: : Peak amfenac concentrations were reached within 1 hour in the anterior segment and within 1-4 hours in the posterior segment. Unilateral dosing showed higher tissue levels in the dosed eye versus the undosed eye indicating appreciable local periocular distribution. A concentration-gradient was observed in the posterior segment, with highest peak concentrations in sclera followed by choroid and then retina. High and sustained concentrations of the prodrug were observed in the conjunctiva, cornea, and sclera, suggesting a depot for continued hydrolysis to the potent COX inhibitor amfenac. Very low vitreous concentrations of both drugs indicate that the posterior segment likely received drug via trans-scleral penetration.

Conclusions: : Following topical instillation, nepafenac and amfenac are readily available to ocular tissues, including the posterior segment, reaching pharmacologically relevent concentrations through scleral and corneal penetration.

Keywords: inflammation • retina • edema 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.